Ex parte RAO et al. - Page 6




          Appeal No. 1996-0683                                                        
          Application 08/116,938                                                      


          Accordingly, we decline to consider them for the purpose of                 
          determining whether the examiner has established a prima facie              
          case of enablement with respect to the relied upon prior art                
          references.  See In re Hoch, 428 F.2d 1341, 1342 n.3, 166 USPQ              
          406, 407 n.1 (CCPA 1970) (“Where a reference is relied on to                
          support a rejection, whether or not in a ‘minor capacity,’                  
          there would appear to be no excuse for not positively                       
          including the reference in the statement of the rejection.”).               
               In view of the foregoing, we reverse the examiner’s                    
          decision rejecting all of the appealed claims (species                      
          described in claim 7) under 35 U.S.C. § 102(b) over the                     
          Zhanxun references.                                                         


               As a final point, we observe that appellants acknowledge               
          (specification, pages 4 and 5) that:                                        
                    U. S. Patent No. 2,975,220 discloses compounds                    
               of the general formula R(CH CF ) Q, where n is an                      
                                          2  2n                                       
               integer and Q is halogen or hydrogen and R is a                        
               halogenated radical.  These compounds (e.g.,                           
               CF CF CH CF CF ) may be prepared by reacting vinylidene                
                 3  2 2 2  3                                                          
               fluoride with certain telogens.                                        
                    There are also means of synthesizing various                      
               fluorine-substituted alkenes.  For example, U.S.                       
               Patent Nos. 4,820,883 and 4,820,884 disclose the use                   

                                         -6-                                          





Page:  Previous  1  2  3  4  5  6  7  8  Next 

Last modified: November 3, 2007